Geode Capital Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.9M | Buy |
2,847,965
+92,719
| +3% | +$2.63M | 0.01% | 1148 |
|
|
2025
Q1 | $81.4M | Sell |
2,755,246
-52,209
| -2% | -$1.54M | 0.01% | 1094 |
|
|
2024
Q4 | $82.8M | Buy |
2,807,455
+222,152
| +9% | +$6.55M | 0.01% | 1114 |
|
|
2024
Q3 | $119M | Buy |
2,585,303
+328,606
| +15% | +$15.1M | 0.01% | 872 |
|
|
2024
Q2 | $92.2M | Buy |
2,256,697
+657,023
| +41% | +$26.8M | 0.01% | 970 |
|
|
2024
Q1 | $40.8M | Buy |
1,599,674
+52,460
| +3% | +$1.34M | ﹤0.01% | 1494 |
|
|
2023
Q4 | $14M | Buy |
1,547,214
+111,661
| +8% | +$1.01M | ﹤0.01% | 2134 |
|
|
2023
Q3 | $9.16M | Sell |
1,435,553
-2,997
| -0.2% | -$19.1K | ﹤0.01% | 2323 |
|
|
2023
Q2 | $16M | Buy |
1,438,550
+136,517
| +10% | +$1.51M | ﹤0.01% | 2011 |
|
|
2023
Q1 | $20M | Buy |
1,302,033
+179,655
| +16% | +$2.76M | ﹤0.01% | 1802 |
|
|
2022
Q4 | $24.9M | Buy |
1,122,378
+182,754
| +19% | +$4.06M | ﹤0.01% | 1627 |
|
|
2022
Q3 | $15.3M | Buy |
939,624
+90,923
| +11% | +$1.48M | ﹤0.01% | 1931 |
|
|
2022
Q2 | $12.3M | Buy |
848,701
+111,605
| +15% | +$1.62M | ﹤0.01% | 2107 |
|
|
2022
Q1 | $13.6M | Buy |
737,096
+22,855
| +3% | +$422K | ﹤0.01% | 2141 |
|
|
2021
Q4 | $17M | Sell |
714,241
-25,025
| -3% | -$595K | ﹤0.01% | 2070 |
|
|
2021
Q3 | $18.2M | Buy |
739,266
+326,589
| +79% | +$8.04M | ﹤0.01% | 2032 |
|
|
2021
Q2 | $10.2M | Buy |
412,677
+7,003
| +2% | +$173K | ﹤0.01% | 2441 |
|
|
2021
Q1 | $8.85M | Buy |
405,674
+140,086
| +53% | +$3.06M | ﹤0.01% | 2438 |
|
|
2020
Q4 | $6.78M | Sell |
265,588
-5,049
| -2% | -$129K | ﹤0.01% | 2413 |
|
|
2020
Q3 | $7.62M | Buy |
270,637
+253,706
| +1,498% | +$7.14M | ﹤0.01% | 2134 |
|
|
2020
Q2 | $478K | Buy |
+16,931
| New | +$478K | ﹤0.01% | 3396 |
|